Selective insulin receptor modulators (SIRM): a new class of antidiabetes drugs?

Diabetes. 2012 May;61(5):984-5. doi: 10.2337/db12-0192.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Blood Glucose / physiology*
  • Diabetes Mellitus, Experimental / therapy*
  • Humans
  • Male
  • Receptor, Insulin / agonists*

Substances

  • Antibodies, Monoclonal
  • Blood Glucose
  • Receptor, Insulin